Skip to content

Sequential Study of the Optimal Dose of Ropivacaine for Subarachnoid Block for External Cephalic Version

Sequential Study of the Optimal Dose of Ropivacaine for Subarachnoid Block for External Cephalic Version

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084126
Enrollment
Unknown
Registered
2024-05-10
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breech pregnancy

Interventions

experimental group:The dose group of ropivacaine assigned to each maternal is obtained by statistical experts based on the Biased Coin up- down sequential method programming and the response of the pr

Sponsors

International Peace Maternity and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Singleton pregnancy, 2. Age= 18 years old, 3. Gestational = 37 weeks, 4. Height 150-180cm, 5. BMI = 40

Exclusion criteria

Exclusion criteria: 1. Contraindications to neuraxial anesthesia, 2. rupture of fetal membranes and fetal intrauterine distress, 3. Refusal to sign informed consent

Design outcomes

Primary

MeasureTime frame
Anesthesia plane;VAS score;

Secondary

MeasureTime frame
systolic pressure per 3 minutes during operation;heart rate per 3 minutes during operation;fetal heart rate per 3 minutes during operation;

Countries

China

Contacts

Public ContactQiao Shi; Ma Rui

International Peace Maternity and Child Health Hospital

shiqiao1305@163.com+86 136 3653 0460

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 22, 2026